Druggable drivers of lung cancer
Oncotarget
.
2013 Sep;4(9):1334-5.
doi: 10.18632/oncotarget.1223.
Authors
Shameem Fawdar
1
,
Zoe C Edwards
,
John Brognard
Affiliation
1
Signalling Networks in Cancer Group, Cancer Research UK Manchester Institute and The University of Manchester, Manchester, UK.
PMID:
23963079
PMCID:
PMC3824536
DOI:
10.18632/oncotarget.1223
No abstract available
Publication types
Editorial
MeSH terms
Disease-Free Survival
Genomics / methods
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / genetics*
Molecular Targeted Therapy / methods
Precision Medicine / methods
Grants and funding
12936/CRUK_/Cancer Research UK/United Kingdom